Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601485-22-000039
Filing Date
2022-05-25
Accepted
2022-05-25 17:58:29
Documents
1
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165351588830337.html 4  
1 FORM 4 wf-form4_165351588830337.xml 4 4513
  Complete submission text file 0001601485-22-000039.txt   5905
Mailing Address C/O AYER CAPITAL MANAGEMENT, LP 230 CALIFORNIA ST, SUITE 600 SAN FRANCISCO CA 94111
Business Address
Venkatesan Jay (Reporting) CIK: 0001413350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 22964367

Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations